Nikayeh Mostofizadeh

Statistics

Publications

Citations

102

H-Index

Active since

2013

Affiliations

Pfizer (United States)(Current)

Nikayeh Mostofizadeh is an author at Pfizer (United States) specializing in antiproliferative agents, pharmacodynamics of anticancer agents, and cancer pharmacology.

Publications per year

2013–2013

Publications

PD-0332991, a potent and selective inhibitor of cyclin-dependent kinase 4/6, demonstrates inhibition of proliferation in renal cell carcinoma at nanomolar concentrations and molecular markers predict for sensitivity.

Joshua E. Logan, Nikayeh Mostofizadeh, Amrita Desai et al. · PubMed · 2013 · 102 citations

Medicine, Oncology, Pharmacology +17

1–1 of 1